Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns

Launched by GEORGE WASHINGTON UNIVERSITY · Nov 12, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new tool called the bili-ruler, which is a low-cost plastic device designed to help detect jaundice in newborns. Jaundice is a common condition in which a newborn's skin and eyes turn yellow due to high levels of bilirubin, a substance produced when the body breaks down red blood cells. While most newborns experience some degree of jaundice, severe cases can lead to serious health issues, including brain damage. The bili-ruler aims to provide an easy and affordable way to screen for jaundice in newborns during their first week of life, comparing its effectiveness to traditional methods like visual checks and other medical devices.

To participate in this study, infants born to mothers who are enrolled in the PRISMA program can join, as long as they do not have skin conditions on their face, nose, or ears that could affect the bilirubin measurements. The trial is not yet recruiting participants, but once it begins, families can expect their newborns to be tested for jaundice using the bili-ruler and possibly other methods. This research could help improve early detection and treatment of jaundice in community settings, ensuring that at-risk babies receive the care they need.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All infants who are born to PRISMA enrolled mothers will be eligible for this study.
• Exclusion Criteria:
• • Presence of skin lesions, abnormalities, etc on the baby's nose, face, and ears, which could interfere with bilirubin measurement, as determined by research staff.